Luye Pharma Current Debt
| LYPHF Stock | USD 0.34 0.03 9.68% |
Luye Pharma Group holds a debt-to-equity ratio of 1.149. . Luye Pharma's financial risk is the risk to Luye Pharma stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Luye Pharma's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Luye Pharma's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Luye Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect Luye Pharma's stakeholders.
For most companies, including Luye Pharma, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Luye Pharma Group, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Luye Pharma's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Luye Pharma's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Luye Pharma is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Luye Pharma to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Luye Pharma is said to be less leveraged. If creditors hold a majority of Luye Pharma's assets, the Company is said to be highly leveraged.
Luye |
Luye Pharma Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Luye Pharma's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Luye Pharma, which in turn will lower the firm's financial flexibility.Understaning Luye Pharma Use of Financial Leverage
Luye Pharma's financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Luye Pharma's total debt position, including all outstanding debt obligations, and compares it with Luye Pharma's equity. Financial leverage can amplify the potential profits to Luye Pharma's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Luye Pharma is unable to cover its debt costs.
Luye Pharma Group Ltd. develops, produces, markets, and sells pharmaceutical products worldwide. The company was founded in 1994 and is headquartered in Yantai, the Peoples Republic of China. Luye Pharma is traded on OTC Exchange in the United States. Please read more on our technical analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Luye Pink Sheet
Luye Pharma financial ratios help investors to determine whether Luye Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Luye with respect to the benefits of owning Luye Pharma security.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.